Valuation: Sunflower Pharmaceutical Group Co., Ltd.

Market Cap 7.79B 1.16B 998M 936M 853M 1.6B 110B 1.63B 10.97B 4.3B 55.36B 4.34B 4.24B 184B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 5.3B 786M 679M 637M 580M 1.09B 75.15B 1.11B 7.46B 2.92B 37.65B 2.95B 2.89B 125B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day-1.26%
1 week-1.19%
Current month-1.33%
1 month-2.20%
3 months-1.11%
6 months-4.78%
Current year-9.68%
1 week 13.06
Extreme 13.06
13.93
1 month 12.91
Extreme 12.91
13.93
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
16.42
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 44 2019-01-06
Director of Finance/CFO 49 2021-12-05
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 66 2014-03-25
Director/Board Member 64 2017-09-25
Director/Board Member 44 2017-09-25
Date Insider Type Main position Quantity % Market Cap.
7/17/24 Buy 500 0.0001%
1/22/20 Sell

Director

246,300 0.0462%
1/1/20 Sell 21,300 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
-1.26%-1.19%-16.52%-42.97% 1.17B
-0.46%-2.72%-11.01%-6.51% 13.24B
-0.16%-2.78%-32.52%-58.08% 4.98B
-0.81%-4.74%+2.32%-1.96% 4.91B
+0.29%+0.71%+7.12%-27.92% 4.2B
-0.03%-2.82%-18.37%+0.19% 3.59B
+0.20%-1.73%-5.07%+11.71% 3.4B
-1.06%-6.33%-8.56%-10.25% 3.35B
+1.19%+1.45%-12.60%-15.66% 2.49B
0.00%+10.60%+3.45%-10.61% 1.81B
Average -0.21%-0.39%-9.18%-16.21% 4.31B
Weighted average by Cap. -0.26%-1.32%-9.80%-14.02%

Financials

2024 2025
Net sales 3.38B 501M 432M 406M 370M 695M 47.9B 705M 4.76B 1.86B 24B 1.88B 1.84B 79.83B 2.32B 344M 297M 278M 254M 477M 32.88B 484M 3.26B 1.28B 16.47B 1.29B 1.26B 54.79B
Net income 492M 72.99M 63.01M 59.12M 53.84M 101M 6.98B 103M 693M 272M 3.5B 274M 268M 11.63B -258M -38.25M -33.02M -30.98M -28.21M -53.05M -3.66B -53.79M -363M -142M -1.83B -144M -140M -6.09B
Net Debt -2.29B -340M -293M -275M -251M -471M -32.47B -478M -3.22B -1.26B -16.27B -1.28B -1.25B -54.12B -2.49B -370M -319M -299M -273M -513M -35.35B -520M -3.51B -1.38B -17.71B -1.39B -1.36B -58.91B
Logo Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
26-08-17 CN¥13.34 -1.26% 7,537,500
26-08-14 CN¥13.51 -0.88% 5,844,800
26-08-13 CN¥13.63 +1.26% 8,321,625
26-08-12 CN¥13.46 -0.81% 5,395,954
26-08-11 CN¥13.57 +0.52% 5,492,848

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock